ConductScience.org, home

Paper39664427

Solubilization techniques used for poorly water-soluble drugs.

Xie B and 4 others. Acta Pharm Sin B, 2024. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. Solubilization techniques used for poorly water-soluble drugs. Papers, record 39664427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39664427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Solubilization techniques used for poorly water-soluble drugs.
PubMed
Journal
Acta Pharm Sin B
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
25.17, provisional
iCite
Revised in PubMed
2024-12-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xie BBing
2Liu YYaping
3Li XXiaotong
4Yang PPei
5He WWei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References524

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136257466Stabilizer-induced different in vivo behaviors for intramuscularly long-acting celecoxib nanocrystals.Int J Pharm2022https://conductscience.org/library/papers/36257466PubMed
236176908Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression.Acta Pharm Sin B2022https://conductscience.org/library/papers/36176908PubMed
336986633Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications.Pharmaceutics2023https://conductscience.org/library/papers/36986633PubMed
426687805Hemolysis by surfactants--A review.Adv Colloid Interface Sci2016https://conductscience.org/library/papers/26687805PubMed
535217484Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy.Biomaterials2022https://conductscience.org/library/papers/35217484PubMed
635456665Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development.Pharmaceutics2022https://conductscience.org/library/papers/35456665PubMed
732172898Thermosensitive and pH-responsive tannin-containing hydroxypropyl chitin hydrogel with long-lasting antibacterial activity for wound healing.Carbohydr Polym2020https://conductscience.org/library/papers/32172898PubMed
830796155A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.Oncologist2019https://conductscience.org/library/papers/30796155PubMed
935026310SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models.Int J Pharm2022https://conductscience.org/library/papers/35026310PubMed
1036216174Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review.J Control Release2022https://conductscience.org/library/papers/36216174PubMed
1136097547Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for Praziquantel.Cryst Growth Des2022https://conductscience.org/library/papers/36097547PubMed
1234976214Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.Theranostics2022https://conductscience.org/library/papers/34976214PubMed
1333359582Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy.J Control Release2021https://conductscience.org/library/papers/33359582PubMed
1433849570Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.J Nanobiotechnology2021https://conductscience.org/library/papers/33849570PubMed
1535970274Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/35970274PubMed
1631144287Siponimod: First Global Approval.Drugs2019https://conductscience.org/library/papers/31144287PubMed
1735112798Structure-Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery Profiles.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35112798PubMed
1829438463Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.Ann Oncol2018https://conductscience.org/library/papers/29438463PubMed
1936341935Inhaled deep eutectic solvent based-nanoemulsion of pirfenidone in idiopathic pulmonary fibrosis.J Control Release2022https://conductscience.org/library/papers/36341935PubMed
2023383426Strategies to address low drug solubility in discovery and development.Pharmacol Rev2013https://conductscience.org/library/papers/23383426PubMed

See all 524 referencesDownload CSV of references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
42972414Translational design of multifunctional novasomes for theranostic-driven precision therapy of cutaneous oncology.J Biol Eng2026https://conductscience.org/library/papers/42972414PubMed
42948712In vivo fate mapping of a paclitaxel-loaded polymeric micelle and its components.Acta Pharm Sin B2026https://conductscience.org/library/papers/42948712PubMed
42946866Overcoming Biopharmaceutical Challenges in the Development of Amorphous Nanosuspension: A Case Study of Atazanavir.AAPS PharmSciTech2026https://conductscience.org/library/papers/42946866PubMed
42939861Naturally Derived Versus Synthetic Salicylic Acid: Physicochemical Properties, Transdermal Permeation and Macrophage Immunomodulation.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939861PubMed
42918941Hot-Stage Microscopy as a Quantitative Preformulation Tool for Assessing API Particle Dissolution in Molten Polymer Matrices.AAPS PharmSciTech2026https://conductscience.org/library/papers/42918941PubMed
42915796Synthesis and Characterization of Naringin Phenolate Salts for Cultivated Meat.J Agric Food Chem2026https://conductscience.org/library/papers/42915796PubMed
42839608Self-Adaptive Biomimetic Nanocomposite Hydrogel Orchestrates Dual-Targeting and On-Demand H2S Gasotransmission for Multifactorial Diabetic Wound Therapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42839608PubMed
42823964A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy.iScience2026https://conductscience.org/library/papers/42823964PubMed
42797342Do We Still Need Chemistry for Water-Soluble Prodrugs? What Biocatalysis Already Does, and What It Does Not.Pharmaceutics2026https://conductscience.org/library/papers/42797342PubMed
42797294Nanococrystals of Diclofenac Acid to Improve Biopharmaceutical Performance: Understanding the Key Drivers.Pharmaceutics2026https://conductscience.org/library/papers/42797294PubMed
42794405Hydrogel-Based Depot Systems in Psychiatric Pharmacotherapy: A Narrative Review Rethinking Long-Acting Drug Delivery.Gels2026https://conductscience.org/library/papers/42794405PubMed
42754781Amorphous Solid Dispersions in Non-Oral Drug Delivery: A Critical Review Bridging Mechanistic Advantages and Gaps in Translational Evidence.Pharm Res2026https://conductscience.org/library/papers/42754781PubMed
42654110Thermoresponsive Solid Dispersion to Enhance Dissolution Profile of Atorvastatin Calcium: An Industrially Sustainable Alternative to Conventional Approaches.Pharmaceutics2026https://conductscience.org/library/papers/42654110PubMed
42589224Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications.Int J Mol Sci2026https://conductscience.org/library/papers/42589224PubMed
42530850Effects of Generic Prednisolone Formulations on the Dissolution Behavior of Mycophenolate Mofetil under Various pH Conditions.Ther Innov Regul Sci2026https://conductscience.org/library/papers/42530850PubMed
42530787Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs.Saudi Pharm J2026https://conductscience.org/library/papers/42530787PubMed
42518474Chain Length-Regulated Poly(styrene-co-maleic acid)/Lipid Nanostructures for Curcumin Encapsulation.ACS Omega2026https://conductscience.org/library/papers/42518474PubMed
42505421Phenotype-Oriented Characterization of NSC828786 Identifies Convergent HPN-AMACR-Associated Transcriptomic Signatures in Prostate Adenocarcinoma and Broad-Spectrum Antiproliferative Activity.Cells2026https://conductscience.org/library/papers/42505421PubMed
42495293Integrating Experimental Physicochemical Data with PBPK Modeling to Guide the Translational Development of the Antifungal 1,3,4-Oxadiazole Derivative LMM6.ACS Omega2026https://conductscience.org/library/papers/42495293PubMed
42469514Mechanistic Insights into Membrane- and Release-Controlled Drug Permeation from Ketoprofen-Lidocaine Eutectic Fluids.Pharm Res2026https://conductscience.org/library/papers/42469514PubMed

See all 71 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39664427

GET https://conductscience.org/api/papers/v1/39664427/references?page=2